Microfluidic Fabrication of MicroRNA-Induced Hepatocyte-Like Cells/Human Umbilical Vein Endothelial Cells-Laden Microgels for Acute Liver Failure Treatment
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Acute liver failure (ALF) is a critical life-threatening disease that occurs due to a rapid loss in hepatocyte functions. Hepatocyte transplantation holds great potential for ALF treatment, as it rapidly supports liver biofunctions and enhances liver regeneration. However, hepatocyte transplantation is still limited by renewable and ongoing cell sources. In addition, intravenously injected hepatocytes are primarily trapped in the lungs and have limited efficacy because of the rapid clearance in vivo . Here, we designed a Y-shaped DNA nanostructure to deliver microRNA-122 (Y-miR122), which could induce the hepatic differentiation and maturation of human mesenchymal stem cells. mRNA sequencing analysis revealed that the Y-miR122 promoted important hepatic biofunctions of the induced hepatocyte-like cells including fat and lipid metabolism, drug metabolism, and liver development. To further improve hepatocyte transplantation efficiency and therapeutic effects in ALF treatment, we fabricated protective microgels for the delivery of Y-miR122-induced hepatocyte-like cells based on droplet microfluidic technology. When cocultured with human umbilical vein endothelial cells in microgels, the hepatocyte-like cells exhibited an increase in hepatocyte-associated functions, including albumin secretion and cytochrome P450 activity. Notably, upon transplantation into the ALF mouse model, the multiple cell-laden microgels effectively induced the restoration of liver function and enhanced liver regeneration. Overall, this study presents an efficient approach from the generation of hepatocyte-like cells to hepatocyte transplantation in ALF therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This engineering environment mimics the structure of the liver and promotes the survival and proliferation of liver cells [38–40].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [39]
Citations
Cites
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
DNA Nanotechnology-Enabled Drug Delivery Systems
Hu, Q., Li, H., Wang, L., Gu, H., & Fan, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00663 · Cited by 1,118
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
Ma, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524510113 · Cited by 872
In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865
Stravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Hu, H., Gehart, H., Artegiani, B., LÖpez-Iglesias, C., Dekkers, F., Basak, O., van Es, J., Chuva de Sousa Lopes, S. M., Begthel, H., Korving, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.013 · Cited by 837
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Hsu, S.-H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 774
Controlled assembly of dendrimer-like DNA
Li, Y., Tseng, Y. D., Kwon, S. Y., d'Espaux, L., Bunch, J. S., McEuen, P. L., & Luo, D. (2004) · Nature Materials · doi:10.1038/nmat1045 · Cited by 482
Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure
Woolbright, B. L., & Jaeschke, H. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.017 · Cited by 390
Research works printed but not linked: 1
- 10.1039/d2mh00314g · DOI
Cited by
Developing fibrin-based biomaterials/scaffolds in tissue engineering
Li, S., Dan, X., Chen, H., Li, T., Liu, B., Ju, Y., Li, Y., Lei, L., & Fan, X. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.006 · Cited by 107
“Hepatic transplantation is currently the sole effective and authoritative therapy for the treatment of liver failure [196]; however, the shortage of liver transplant donors and possible immune rejection remain ongoing challenges.”
BackgroundFeng, Y., Zhang, X., Li, J., Fu, S., Xu, W., Liu, J., Yang, Y., Chen, T., Zhao, Y., Li, D., et al. (2024) · Theranostics · doi:10.7150/thno.103746 · Cited by 40
Jin, Y., Zhang, J., Chen, X., Li, F., Xue, T., Yi, K., Xu, Y., Wang, H., Lao, Y., Chan, H. F., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122895 · Cited by 37
Self-citationChen, X., Zhang, J., Lin, T., Zhou, F., Li, F., Xue, T., Zhong, Q., Lee, W., Chen, G., Wang, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c13709 · Cited by 30
Self-citationYang, X., Li, C., Jiao, Y., Wang, L., & Wang, F. (2025) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c02487 · Cited by 14
Metadata
- Authors
- Li, F., Wei, H., Jin, Y., Xue, T., Xu, Y., Wang, H., Ju, E., Tao, Y., & Li, M.
- Affiliations
- Sun Yat-sen University (CN)
- Corresponding author
- Tao, Yu
- Li, Mingqiang
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-12-08
- Volume
- 17
- Issue
- 24
- Pages
- 25243-25256
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W4389488277
- Cited by
- 23
- References
- 56
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 5
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development Program of China (2019YFA0111300)
- Guangdong Provincial Pearl River Talents Program (2019QN01Y131)
- China Primary Health Care Foundation (2022-003)
- Guangzhou Municipal Science and Technology Project (202102010217, 202102010225)
- National Natural Science Foundation of China (52373166, 52202359, 22277155, 32001012)
- Recruitment Program of Global Experts
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- acute liver failure, hepatocyte-like cells, miR-122, mesenchymal stem cell differentiation, hepatocyte transplantation, human umbilical vein endothelial cells, droplet microfluidics, liver regeneration, cytochrome P450 activity, albumin secretion, cell delivery
- MeSH terms
- Microgels, Animals, Cell Differentiation, Humans, Liver, Liver Failure, Acute, Hepatocytes, MicroRNAs, Microfluidics, Mesenchymal Stem Cell Transplantation, Mice, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.